Inventor of
Combinations of therapeutic agents for treating uveal melanoma
Patent application(s)
WO2020239685
( 02 December 2020 )
NEUROBLASTOMA PROGNOSTIC MULTIGENE EXPRESSION SIGNATURE
Patent application(s)
WO2010066851
( 16 June 2010 )
Granted patent(s)
EP2364369
( 28 July 2015 )
Usages of recombinant extracellular vesicles
Patent application(s)
WO2019091964
( 15 May 2019 )
Granted patent(s)
EP3483588
( 05 November 2019 )
Method to screen, diagnose or monitor treatment using increased numbers of deviating analytes
Patent application(s)
WO2024200811
( 02 October 2024 )
Biomarkers for disease burden of neuroblastoma
Patent application(s)
WO2019115214
( 19 June 2019 )
Granted patent(s)
EP3724356
( 23 January 2024 )
Inhibition of a lncRNA for treatment of neuroblastoma
Patent application(s)
WO2019149616
( 07 August 2019 )
Granted patent(s)
EP3746555
( 29 March 2022 )
Inhibition of a lncRNA for treatment of melanoma
Patent application(s)
WO2015024986
( 25 February 2015 )
Granted patent(s)
USRE048801
( 01 November 2021 )